What changed today in Aesthetics & Longevity: 6 new studies, 4 trial updates, 1 FDA announcement

Why this matters

New clearances, safety communications and research in aesthetic and regenerative medicine affect what practices offer, how they describe it and what patients are told.

Source file

1. [1]
   New trial registered: AnteAGE Biosomes With Radiofrequency Microneedling for Facial Skin Rejuvenation (opens the source in a new tab)

   Primary sourceClinicalTrials.gov (U.S. National Library of Medicine)Sep 29, 2026

2. [2]
   New trial registered: AnteAGE Exosomes and PEARL Multiplier With Microneedling for Facial Skin Quality (opens the source in a new tab)

   Primary sourceClinicalTrials.gov (U.S. National Library of Medicine)Sep 29, 2026

3. [3]
   New trial registered: Evidence-Based Integrated Protocol to Maximize Hair Follicle Survival in Follicular Unit Extraction (FUE) (opens the source in a new tab)

   Primary sourceClinicalTrials.gov (U.S. National Library of Medicine)Sep 29, 2026

4. [4]
   Numerical simulation of PDRN iontophoresis: comparison with passive diffusion and key parameter analysis (opens the source in a new tab)

   Peer reviewedDrug deliverySep 24, 2026

5. [5]
   Skin organoid-derived exosomes in a hydrogel system potentiate skin wound healing (opens the source in a new tab)

   Peer reviewedMaterials today. BioSep 30, 2026

6. [6]
   Preparation of oxygen-filled adipose-derived stem cells exosome-nanobubbles gel for ultrasound-assisted full-thickness wound healing in rats (opens the source in a new tab)

   Peer reviewedBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapieSep 30, 2026

7. [7]
   PRP-Integrated Conductive Hydrogels With Dynamic Crosslinking for Accelerated Wound Healing and Physiological Monitoring (opens the source in a new tab)

   Peer reviewedAdvanced healthcare materialsSep 28, 2026

8. [8]
   TGα2β-modified adipose-derived stem cell exosomes regulate collagen synthesis in fibroblasts and enhance chronic ulcerative wound repair through the ILK/AKT signaling pathway (opens the source in a new tab)

   Peer reviewedPakistan journal of pharmaceutical sciencesOct 1, 2026

9. [9]
   Results posted on ClinicalTrials.gov: A Study to Assess Adverse Events of Intramuscular AGN-151586 Injection in Adult Participants With Glabellar Lines (opens the source in a new tab)

   Primary sourceClinicalTrials.gov (U.S. National Library of Medicine)Sep 24, 2026

10. [10]
    FDA Investigation Leads to Charges Against Two Indian Nationals Involved in Transnational Counterfeit Drug Distribution Scheme (opens the source in a new tab)

    Primary sourceU.S. Food and Drug AdministrationSep 29, 2026

11. [11]
    Dermatology FDA and Pipeline Review: Q3 2026 Approvals and Readouts (opens the source in a new tab)

    News reportingDermatology TimesSep 29, 2026Industry coverage — headline and link only

12. [12]
    Alopecia Areata Awareness Month: 2026 in Review (opens the source in a new tab)

    News reportingDermatology TimesSep 28, 2026Industry coverage — headline and link only

13. [13]
    ValueCap Becomes Silver Vendor Affiliate with the American Med Spa Association (opens the source in a new tab)

    News reportingAmerican Med Spa AssociationSep 28, 2026Industry coverage — headline and link only

Compiled automatically from primary official sources and peer-reviewed literature. Each line is a factual summary of a public record, linked to it — no interpretation is added. NPHLA links to sources and does not republish their text. Professional information only — not medical, legal or regulatory advice for any individual situation. Our standards.

Update timeline

1. Oct 1, 2026, 5:05 AM EDTFirst published.
2. Oct 1, 2026, 5:08 AM EDTAdded 5 new official records.